Send feedback

MRAS p.Pro44=

c.132C>T · VCV3697154

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00281%, afr)
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.57GERP -0.078, phastCons 0.02
Overall
CADD9.562PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00281% African / African-American · 2/71,110 alleles
Filtering AF 0.000467% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000175%
Overall 0.00045% 7/1,556,298 alleles · very rare exomes 6/1,404,116 · genomes 1/152,182 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.00281% 35,555
Remaining individualsnot grpmax-eligible 0.00166% 60,126
European (non-Finnish) 0.000347% 288,506

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MRAS
Protein
p.Pro44=
Coding
c.132C>T
MANE Select
NM_001085049
Type
single nucleotide variant
Location
chr3:138373015 (GRCh38)
Gene constraint
LOEUF 0.444 · pLI 0.99 (gnomAD)
Structure
AlphaFold pLDDT 86.61 · 11 PDB
Residue 44
a binding site
Full MRAS gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mras-p-pro44 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown